Optical coherence tomography: A quantitative tool to measure neurodegeneration and facilitate testing of novel treatments for tissue protection in multiple sclerosis

Eliza Gordon-Lipkin, Peter Calabresi

Research output: Contribution to journalArticle

Abstract

Optical coherence tomography (OCT) is a relatively new imaging technology that has been introduced as a powerful biomarker in neurological disease, including multiple sclerosis. In this review, OCT as an imaging technique, its reproducibility and validation in multiple sclerosis, application to other neurodegenerative diseases and future technological directions are discussed.

Original languageEnglish (US)
Pages (from-to)93-96
Number of pages4
JournalJournal of Neuroimmunology
Volume304
DOIs
StatePublished - Mar 15 2017

Fingerprint

Optical Coherence Tomography
Multiple Sclerosis
Neurodegenerative Diseases
Biomarkers
Technology
Direction compound

Keywords

  • Multiple sclerosis
  • Neurodegeneration
  • Neuroimaging
  • Optical coherence tomography

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology

Cite this

@article{f374cf2c175f4e648ec8d07c45f18397,
title = "Optical coherence tomography: A quantitative tool to measure neurodegeneration and facilitate testing of novel treatments for tissue protection in multiple sclerosis",
abstract = "Optical coherence tomography (OCT) is a relatively new imaging technology that has been introduced as a powerful biomarker in neurological disease, including multiple sclerosis. In this review, OCT as an imaging technique, its reproducibility and validation in multiple sclerosis, application to other neurodegenerative diseases and future technological directions are discussed.",
keywords = "Multiple sclerosis, Neurodegeneration, Neuroimaging, Optical coherence tomography",
author = "Eliza Gordon-Lipkin and Peter Calabresi",
year = "2017",
month = "3",
day = "15",
doi = "10.1016/j.jneuroim.2016.12.003",
language = "English (US)",
volume = "304",
pages = "93--96",
journal = "Journal of Neuroimmunology",
issn = "0165-5728",
publisher = "Elsevier",

}

TY - JOUR

T1 - Optical coherence tomography

T2 - A quantitative tool to measure neurodegeneration and facilitate testing of novel treatments for tissue protection in multiple sclerosis

AU - Gordon-Lipkin, Eliza

AU - Calabresi, Peter

PY - 2017/3/15

Y1 - 2017/3/15

N2 - Optical coherence tomography (OCT) is a relatively new imaging technology that has been introduced as a powerful biomarker in neurological disease, including multiple sclerosis. In this review, OCT as an imaging technique, its reproducibility and validation in multiple sclerosis, application to other neurodegenerative diseases and future technological directions are discussed.

AB - Optical coherence tomography (OCT) is a relatively new imaging technology that has been introduced as a powerful biomarker in neurological disease, including multiple sclerosis. In this review, OCT as an imaging technique, its reproducibility and validation in multiple sclerosis, application to other neurodegenerative diseases and future technological directions are discussed.

KW - Multiple sclerosis

KW - Neurodegeneration

KW - Neuroimaging

KW - Optical coherence tomography

UR - http://www.scopus.com/inward/record.url?scp=85009355123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009355123&partnerID=8YFLogxK

U2 - 10.1016/j.jneuroim.2016.12.003

DO - 10.1016/j.jneuroim.2016.12.003

M3 - Article

C2 - 28038893

AN - SCOPUS:85009355123

VL - 304

SP - 93

EP - 96

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

SN - 0165-5728

ER -